U.S., Nov. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07945145) titled 'A Pharmacokinetics Study of GZR33 Injection at Different Injection Sites' on Nov. 07.

Brief Summary: This trial is conducted in China. This study will be conducted to evaluate the pharmacokinetics and safety of GZR33 Injection administered at different injection sites in healthy participants.

Study Start Date: Dec. 16

Study Type: INTERVENTIONAL

Condition: Healthy Participants

Intervention: DRUG: GZR33 Injection

Administered subcutaneously (s.c.)

DRUG: GZR33 Injection

Administered subcutaneously (s.c.)

DRUG: GZR33 Injection

Administered subcutaneously (s.c.)

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Gan & Lee Pharm...